Glioma-on-a-Chip Models

Glioma, as an aggressive type of cancer, accounts for virtually 80% of malignant brain tumors. Despite advances in therapeutic approaches, the long-term survival of glioma patients is poor (it is usually fatal within 12–14 months). Glioma-on-chip platforms, with continuous perfusion, mimic in vivo m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ustun, Merve, Rahmani Dabbagh, Sajjad, Ilci, Irem Sultan, Bagci-Onder, Tugba, Tasoglu, Savas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145995/
https://www.ncbi.nlm.nih.gov/pubmed/33926127
http://dx.doi.org/10.3390/mi12050490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145995/
https://www.ncbi.nlm.nih.gov/pubmed/33926127
http://dx.doi.org/10.3390/mi12050490

Ejemplares similares